Super Investors Be Like
ISRG

Intuitive Surgical — Income Statement, Cash Flows & Balance Sheet

AI Overview

Is Intuitive Surgical profitable?

Intuitive Surgical is growing fast and becoming more profitable, with revenue crossing $10 billion for the first time.

Metric20242025Change
Total revenue$8,352M$10,065M+20.5%
Gross profit$5,634M$6,642M+17.9%
Gross margin67.4%66.0%−1.4 pp
Income from operations$2,349M$2,946M+25.4%
Net income (attributable to Intuitive)$2,323M$2,856M+23.0%

Revenue grew at a brisk double-digit pace and operating income grew even faster, showing operating leverage. Gross margin dipped slightly — a reflection of the cost to manufacture and deploy a growing fleet of surgical systems — but remains very healthy.

A low effective tax rate amplified net income, though the underlying business is genuinely strong.

Metric20242025Change
Income before taxes$2,674M$3,311M+23.8%
Income tax expense$336M$435M+29.3%
Effective tax rate12.6%13.1%+0.5 pp

The effective tax rate of 13% is well below the statutory 21%, driven largely by a $211M tax benefit from employee stock option exercises. This is a real and recurring benefit for Intuitive, but worth noting that pre-tax profit growth is what's doing the heavy lifting.

Where does Intuitive Surgical's revenue come from?

Instruments and accessories — the consumables that hospitals buy every time they perform a surgery — are the largest and fastest-growing revenue stream.

Revenue Type20242025Change
Instruments & accessories$5,079M$6,019M+18.5%
Systems$1,966M$2,474M+25.8%
Services$1,307M$1,572M+20.3%
Total$8,352M$10,065M+20.5%

All three categories grew strongly. Systems revenue (selling new da Vinci and Ion platforms) surged — a sign hospitals are still expanding their robotic surgery capacity — while instruments and accessories, which recur with every procedure, form the durable revenue base.

The U.S. market is the primary growth engine, though international demand is solid too.

Geography20242025Change
U.S.$5,589M$6,816M+22.0%
Outside U.S. (OUS)$2,763M$3,249M+17.6%
Total$8,352M$10,065M+20.5%

Domestic revenue, which accounts for about two-thirds of the total, outpaced international growth. International remains meaningful and growing, representing a long-term expansion opportunity.

Does Intuitive Surgical generate cash?

Intuitive converts its profits into real cash reliably, with operating cash flow topping $3 billion.

Metric20242025Change
Net cash from operations$2,415M$3,031M+25.5%
Capital expenditures$1,111M$540M−51.4%
Free cash flow (GAAP operating CF minus capex)$1,304M$2,491M+91.1%

Free cash flow nearly doubled, partly because 2024 was an unusually heavy capital spending year (building out manufacturing and facilities). With that investment cycle winding down, significantly more cash was available in 2025.

Intuitive returned $2.3 billion to shareholders through buybacks — its largest repurchase program on record.

Activity20242025Change
Shares repurchased04.8M
Value of buybacks$0M$2,301M

After no buybacks in 2024, the company aggressively returned cash to shareholders in 2025, reducing the share count modestly. Approximately $1.7 billion of buyback authority remains on the board's current program.

How strong is Intuitive Surgical's balance sheet?

Intuitive carries no traditional debt — its balance sheet is fortress-like, with nearly $9 billion in cash and investments.

Metric20242025Change
Cash & equivalents$2,027M$3,368M+66.1%
Short-term investments$1,986M$2,567M+29.3%
Long-term investments$4,819M$3,099M−35.7%
Total cash + investments$8,832M$9,034M+2.3%
Total debt$0$0
Total liabilities$2,214M$2,517M+13.7%

The shift from long-term to short-term investments and cash reflects the large buyback and ongoing business investment, but total financial assets are essentially unchanged and dwarf total liabilities by more than 3.5 to 1. This is an unusually clean balance sheet.